Replimune stock cratered Tuesday after the Food and Drug Administration unexpectedly rejected its experimental melanoma ...

Aquestive Therapeutics, Inc. (NASDAQ: AQST) ('Aquestive” or the 'Company”), a pharmaceutical company advancing medicines to bring meaningful improvement to patients' lives through innovative science ...

With a baby on the way, Nathan Kirkland was facing a rare, aggressive form of bile duct cancer. Kirkland’s bills piled up as ...

Testosterone propionate was once a common treatment for men with low testosterone. It’s a synthetic version of the naturally ...

Drugmaker Sarepta Therapeutics said late Friday it won't comply with a request from the Food and Drug Administration to halt ...

Unaudited Preliminary Financial Results for the Second Quarter Ended June 30, 2025 Net revenue of $720 million to $730 ...

Results Reflect Continued Financial Strength and Deleveraging - BRIDGEWATER, N.J., July 21, 2025 (GLOBE NEWSWIRE) -- Amneal Pharmaceuticals, Inc. (Nasdaq: AMRX) ("Amneal" or the "Company") today annou ...

Regulators plan to integrate ibogaine treatment into Colorado’s psychedelic healing industry. Still, the drug faces an uncertain future.

After the approval of immune checkpoint inhibitors, overall survival among US patients with advanced-stage cancer improved, but disparities between uninsured and privately insured widened.

In a groundbreaking move, the FDA has approved a new UV light-based process for sanitizing raw milk — one that preserves its ...

The U.S. Food and Drug Administration made the controversial decision to authorize the sale of Juul e-cigarettes, including ...

Sarepta rebuffed a call from the Food and Drug Administration to halt all shipments of its gene therapy for Duchenne muscular ...